Indication
high-risk non-muscle-invasive bladder cancer
1 clinical trial
1 product
Product
ZH9Clinical trial
A Phase 1/1b Study Evaluating the Safety, Pharmacology, and Clinical Effect of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder CancerStatus: Recruiting, Estimated PCD: 2025-02-03